Steve Antoline is Director & 10% at Protea Biosciences Group, Inc. (NONE). They have made 1 open-market trade across 1 company since 2011, most recently 2017-03-24.
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $1.6M since 2011, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| PrivateUnlisted | 1,754,048 | — |
| PRGB | 26,325,894 | — |
| Total | $0 |
Shares reported on the most recent Form 4, priced at the 2017-04-04 close. 2 holdings could not be priced and are excluded from the total.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PrivateProtea Biosciences Group, Inc. | BUY | 2011-09-30 | 2014-02-13 | $0.56 | $1.6M | N/A | N/A | N/A |